期刊文献+

奥氮平治疗脑器质性精神障碍临床分析 被引量:4

Clinical analysis on olanzapine in treatment of cerebral organic mental disorders
在线阅读 下载PDF
导出
摘要 目的观察奥氮平治疗脑器质性精神障碍的疗效和不良反应。方法对脑器质性精神障碍患者33例给予奥氮平治疗4周,以简明精神病量表(BPRS)和临床疗效总评量表(CGI-SI)评定精神症状与治疗效果,用不良反应量表(TESS)评定不良反应。结果治疗后BPRS评分及CGI-SI评分较治疗前显著下降,差异有统计学意义(P<0.01)。治疗后总有效率为81.8%(27/33)。TESS评分治疗前后比较,差异无统计学意义(P>0.05)。结论奥氮平治疗脑器质性精神障碍具有较好的疗效和安全性。 Objective To observe the effect and adverse reactions of olanzapine in the treatment of brain organic mental disorders.Methods 33 cases of cerebral organic mental disorders were treated with olanzapine for 4 weeks.The psychotic symp toms and the therapeutic effects were assessed by the Brief Psychiatric Rating Scale(BPRS) and the Clinical G1obal Impression Scale(CGI-SI),and Treatment Emergent Symptom Scale(TESS) was used to evaluate the adverse reactions.Results The scores of BPRS and CGI-GI after treatment were decreased significantly than those before treatment,the difference showing statistical significance(P0.01).The total effective rate after treatment was 81.8%(27/33).There were no significant difference in TESS between before and after treatment(P0.05).Conclusion Olanzapine has better effective and safety in the treatment of cerebral organic mental disorders.
作者 陈伟 聂文燕
出处 《现代医药卫生》 2013年第14期2122-2122,2124,共2页 Journal of Modern Medicine & Health
关键词 苯二氮类 精神障碍 器质性精神障碍 奥氮平 Benzodiazepines Mental disorders Brain Organic mental disorders Oanzapine
  • 相关文献

参考文献11

二级参考文献35

  • 1唐建良,费玉娥,马永春,金卫东.奥氮平与奋乃静治疗高龄精神障碍的对照比较[J].浙江临床医学,2006,8(6):588-589. 被引量:6
  • 2孙仕友.住院精神疾病患者合并躯体疾病调查[J].临床精神医学杂志,2007,17(1):42-43. 被引量:32
  • 3Street JS,Clark WS,Gannon KS,et al.Olanzapine in treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities[J].Arch Gen Psychiatry,2000;57:967-78.
  • 4Poyurovsky M,Tal V,Maayan R,et al.The effect of famotidine addition on olanzapine induced weight gain in first-episode schizophrenia patients:a double-blind placebo controlled pilot study[J].Eur Neuropsychopharmacol,2004;14(4):332.
  • 5[1]Bymaster FP,Calligaro DO,Falcone JF,et al.Radioreceptor binding profile of the atypical antipsychotic olanzapine.Neuropsychopharmacology ,1996,14:87
  • 6[2]Kapur S,Zipursky RB,Remington G,et al.Clinical and theor etical implications of 5-HT2 and D2 receptor occupancy of clozapine,risperi dole,and olanzapine in schizophreia.Am J Psychiatry,1999,156:286
  • 7[3]Arnt J,Skarsfeldt J.Do noval antipsychotics have similar pharmacological characteristics?a review of the evidence.Neuropsychopharmacolog y,1998,16:63
  • 8[4]Bymaster FP.In vivo and in vitro biochemistry of olanzap ine.J Clin Psychiatry,1997,58(suppl 10):28
  • 9[5]Tandon R,Milner K,Jibson MD.Antipsychotics from theory t o practice:integrating clinical and basic data.J Clin Psychiatry,1999,60(suppl 8 ):21
  • 10[6]Beasley CM,Tollefson GD,Tran PV,et al.The efficacy of ol anzapine:the summary of global,multicentral clinical trials.J Clin Psychiatry,19 97,58(suppl 10):7

共引文献801

同被引文献25

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部